Multiple sclerosis vs Lyme disease: A case presentation to a discussant and a review of the literature
暂无分享,去创建一个
[1] T. Christensen,et al. A single subtype of Epstein–Barr virus in members of multiple sclerosis clusters , 1998, Acta neurologica Scandinavica.
[2] M. Kaplan,et al. Human Herpesvirus-6 (HHV-6) infection in multiple sclerosis: a preliminary report , 1998, Multiple sclerosis.
[3] S. Bergström,et al. Augmented intrathecal secretion of interferon-γ in response to Borrelia garinii in neuroborreliosis , 1998, Journal of Neuroimmunology.
[4] L. Leocani,et al. Neurophysiological and cognitive markers of disease evolution in multiple sclerosis , 1998, Multiple sclerosis.
[5] A. Steere,et al. Reversible cerebral hypoperfusion in Lyme encephalopathy , 1997, Neurology.
[6] R. Kinkel,et al. Management of multiple sclerosis. , 1997, The New England journal of medicine.
[7] R Kikinis,et al. Serial neuropsychological assessment and magnetic resonance imaging analysis in multiple sclerosis. , 1997, Archives of neurology.
[8] C. Hughes,et al. Interleukin-6 is expressed at high levels in the CNS in Lyme neuroborreliosis , 1997, Neurology.
[9] K. Becker,et al. Analysis of a sequenced cDNA library from multiple sclerosis lesions , 1997, Journal of Neuroimmunology.
[10] E. Aberer,et al. Why is chronic Lyme borreliosis chronic? , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[11] W. Lüke,et al. Detection of CSF-specific oligoclonal antibodies to recombinant JC virus VP1 in patients with progressive multifocal leukoencephalopathy , 1997, Journal of Neuroimmunology.
[12] A. Pennekamp,et al. [Chronic neuroborreliosis with gait ataxia and cognitive disorders]. , 1997, Praxis.
[13] R. Kaplan,et al. Lyme encephalopathy: a neuropsychological perspective. , 1997, Seminars in neurology.
[14] G. Wormser,et al. Treatment and Prevention of Lyme Disease, with Emphasis on Antimicrobial Therapy for Neuroborreliosis and Vaccination , 1997, Seminars in neurology.
[15] J. Benach,et al. Mechanisms of Injury in Lyme Neuroborreliosis , 1997, Seminars in neurology.
[16] G. Burmester,et al. An optimized PCR leads to rapid and highly sensitive detection of Borrelia burgdorferi in patients with Lyme borreliosis , 1997, Journal of clinical microbiology.
[17] J. Halperin. Neuroborreliosis: Central Nervous System Involvement , 1997, Seminars in neurology.
[18] L. Sigal,et al. Immunologic Mechanisms in Lyme Neuroborreliosis: The Potential Role of Autoimmunity and Molecular Mimicry , 1997, Seminars in neurology.
[19] T. Christensen,et al. The implications of Epstein‐Barr virus in multiple‘ sclerosis ‐ a review , 1997, Acta neurologica Scandinavica. Supplementum.
[20] J. Ruutiainen,et al. The progress of cognitive decline in multiple sclerosis. A controlled 3-year follow-up. , 1997, Brain : a journal of neurology.
[21] B. Schmidt. PCR in laboratory diagnosis of human Borrelia burgdorferi infections , 1997, Clinical microbiology reviews.
[22] J. Pardo,et al. [Diagnosis and treatment of facial palsy]. , 1997, Neurologia.
[23] C. Martyn,et al. Infection in childhood and neurological diseases in adult life. , 1997, British medical bulletin.
[24] H. Kalimo,et al. Inflammatory brain changes in Lyme borreliosis. A report on three patients and review of literature. , 1996, Brain : a journal of neurology.
[25] S. Medendorp,et al. Low-dose oral methotrexate in chronic progressive multiple sclerosis , 1996, Neurology.
[26] N. Schatz,et al. Lyme neuroborreliosis masquerading as a brainstem tumor in a 15-year-old. , 1996, Pediatric neurology.
[27] J. Ruutiainen,et al. Language functions in incipient cognitive decline in multiple sclerosis , 1996, Journal of the Neurological Sciences.
[28] J. Meulstee,et al. Cytomegalovirus infection and Guillain-Barre syndrome , 1996, Neurology.
[29] C. Schmid,et al. Detection of Borrelia burgdorferi DNA by polymerase chain reaction in cerebrospinal fluid in Lyme neuroborreliosis. , 1996, The Journal of infectious diseases.
[30] J. Ruutiainen,et al. Memory deficits and early cognitive deterioration in MS , 1996, Acta neurologica Scandinavica.
[31] A. Malmborg,et al. Concentrations of doxycycline and penicillin G in sera and cerebrospinal fluid of patients treated for neuroborreliosis , 1996, Antimicrobial agents and chemotherapy.
[32] R. Zbinden,et al. Value of clinical symptoms, intrathecal specific antibody production and PCR in CSF in the diagnosis of childhood Lyme neuroborreliosis. , 1996, Klinische Padiatrie.
[33] P. Matzinger,et al. Neonatal Tolerance Revisited: Turning on Newborn T Cells with Dendritic Cells , 1996, Science.
[34] P. Lehmann,et al. Induction of TH1 and TH2 Immunity in Neonatal Mice , 1996, Science.
[35] K. Wood,et al. New concepts in tolerance. , 1996, Clinical transplantation.
[36] W. Tourtellotte,et al. Herpes simplex virus in postmortem multiple sclerosis brain tissue. , 1996, Archives of neurology.
[37] W. Tourtellotte,et al. Detection of herpesviridae in postmortem multiple sclerosis brain tissue and controls by polymerase chain reaction. , 1996, Journal of neurovirology.
[38] H. Link,et al. Lyme Neuroborreliosis: Evidence for Persistent Up‐Regulation of Borrelia Burgdorferi‐Reactive Cells Secreting Interferon‐γ , 1995, Scandinavian journal of immunology.
[39] J. Benach,et al. Experimental immunization with Borrelia burgdorferi induces development of antibodies to gangliosides , 1995, Infection and immunity.
[40] Massimo Filippi,et al. Brain MRI correlates of cognitive impairment in primary and secondary progressive multiple sclerosis , 1995, Journal of the Neurological Sciences.
[41] A. Pachner,et al. Neuroborreliosis in the nonhuman primate: Borrelia burgdorferi persists in the central nervous system , 1995, Annals of neurology.
[42] B. Jacobs,et al. Anti‐GM1 IgG antibodies and campylobacter bacteria in Guillain‐Barré syndrome: Evidence of molecular mimicry , 1995, Annals of neurology.
[43] P. Morlat,et al. Manifestations neurologiques de la maladie de Lyme. propos de 25 cas , 1995 .
[44] A Revonsuo,et al. Attention related performance in two cognitively different subgroups of patients with multiple sclerosis. , 1995, Journal of neurology, neurosurgery, and psychiatry.
[45] G. Burmester,et al. A Role for T Cells in the Pathogenesis of Treatment-Resistant Lyme Arthritis , 1995, Molecular medicine.
[46] N. Koch-Henriksen,et al. Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study , 1995, Multiple sclerosis.
[47] J. Benach,et al. Lyme neuroborreliosis , 1995, Annals of neurology.
[48] T. Benke,et al. Lyme encephalopathy: long‐term neuropsychological deficits years after acute neuroborreliosis , 1995, Acta neurologica Scandinavica.
[49] L. Magnarelli. Current status of laboratory diagnosis for Lyme disease. , 1995, The American journal of medicine.
[50] R. Kaiser. Intrathecal immune response in neuroborreliosis: importance of cross-reactive antibodies. , 1995, Zentralblatt fur Bakteriologie : international journal of medical microbiology.
[51] Y. Lobet,et al. Simultaneous presence of different Borrelia burgdorferi genospecies in biological fluids of Lyme disease patients , 1995, Journal of clinical microbiology.
[52] S. Medendorp,et al. Low‐dose (7.5 mg) oral methotrexate reduces the rate of progression in chronic progressive multiple sclerosis , 1995, Annals of neurology.
[53] J. Ragnaud,et al. [Neurologic manifestations of Lyme disease. Apropos of 25 cases]. , 1995, La Revue de medecine interne.
[54] M. Lana-Peixoto. Multiple sclerosis and positive Lyme serology. , 1994, Arquivos de neuro-psiquiatria.
[55] M. Munch,et al. Increased risk of multiple sclerosis after late Epstein-Barr virus infection. A historical prospective study , 1994, Journal of Neuroimmunology.
[56] A. Revonsuo,et al. Automatic and controlled information processing in multiple sclerosis. , 1994, Brain : a journal of neurology.
[57] J. Koziol,et al. Cladribine in treatment of chronic progressive multiple sclerosis , 1994, The Lancet.
[58] R. Zbinden,et al. Comparison of two methods for detecting intrathecal synthesis of Borrelia burgdorferi-specific antibodies and PCR for diagnosis of Lyme neuroborreliosis , 1994, Journal of clinical microbiology.
[59] L. Lindquist,et al. Comparison of intravenous penicillin G and oral doxycycline for treatment of Lyme neuroborreliosis , 1994, Neurology.
[60] H. Hansen,et al. A Putative New Retrovirus Associated with Multiple Sclerosis and the Possible Involvement of Epstein‐Barr Virus in This Disease a , 1994, Annals of the New York Academy of Sciences.
[61] H. Pfister,et al. Lyme borreliosis: basic science and clinical aspects , 1994, The Lancet.
[62] Sigal Lh. Persisting symptoms of Lyme disease--possible explanations and implications for treatment. , 1994 .
[63] L. Sigal. Persisting complaints attributed to chronic Lyme disease: possible mechanisms and implications for management. , 1994, The American journal of medicine.
[64] M. Peterson,et al. Lyme disease: an infectious and postinfectious syndrome. , 1994, The Journal of rheumatology.
[65] R. Zbinden,et al. [Demonstration of intrathecal antibody formation against Borrelia burgdorferi in Lyme neuroborreliosis]. , 1993, Schweizerische medizinische Wochenschrift.
[66] Coyle Pk. Neurologic complications of Lyme disease. , 1993 .
[67] L. Krupp,et al. Significance of reactive lyme serology in multiple sclerosis , 1993, Annals of neurology.
[68] T. Miyatake,et al. A bacterium lipopolysaccharide that elicits Guillain-Barre syndrome has a GM1 ganglioside-like structure , 1993, The Journal of experimental medicine.
[69] A. Steere. Lyme disease--1993. , 1993, Bulletin on the rheumatic diseases.
[70] J. Kurtzke. Epidemiologic evidence for multiple sclerosis as an infection , 1993, Clinical Microbiology Reviews.
[71] A. Vogt,et al. Intrathecal antibody synthesis in Lyme neuroborreliosis: use of recombinant p41 and a 14-kDa flagellin fragment in ELISA. , 1993, Journal of medical microbiology.
[72] C. Lücking,et al. Intrathecal synthesis of specific antibodies in neuroborreliosis comparison of different ELISA techniques and calculation methods , 1993, Journal of the Neurological Sciences.
[73] J. Heesemann,et al. The spectrum of immune responses to Campylobacter jejuni and glycoconjugates in Guillain‐Barré syndrome and in other neuroimmunological disorders , 1993, Annals of neurology.
[74] C. Lücking,et al. Intrathecal synthesis of IgM and IgA in neurological diseases: comparison of two formulae with isoelectric focusing. , 1993, Clinica chimica acta; international journal of clinical chemistry.
[75] A. Steere,et al. Reactivity of neuroborreliosis patients (Lyme disease) to cardiolipin and gangliosides , 1993, Journal of the Neurological Sciences.
[76] D. Klein,et al. Psychiatric manifestations of Lyme borreliosis. , 1993, The Journal of clinical psychiatry.
[77] A. Steere,et al. Association of treatment-resistant chronic Lyme arthritis with HLA-DR4 and antibody reactivity to OspA and OspB of Borrelia burgdorferi , 1993, Infection and immunity.
[78] A. Steere,et al. The overdiagnosis of Lyme disease. , 1993, JAMA.
[79] G. Comi,et al. Brain magnetic resonance imaging correlates of cognitive impairment in multiple sclerosis , 1993, Journal of the Neurological Sciences.
[80] D. Burdge,et al. EXPERIENCE AT A REFERRAL CENTER FOR PATIENTS WITH SUSPECTED LYME DISEASE IN AN AREA OF NONENDEMICITY: FIRST 65 PATIENTS , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[81] S. Williams,et al. Molecular mimicry in Lyme disease: monoclonal antibody H9724 to B. burgdorferi flagellin specifically detects chaperonin-HSP60. , 1993, Biochimica et biophysica acta.
[82] Å. Sidén,et al. Intrathecal Synthesis of Anti‐Borrelia burgdorferi Antibodies in Neuroborreliosis: a Study with Special Emphasis on Oligoclonal IgM Antibody Bands , 1993, Scandinavian journal of immunology.
[83] C. Martyn,et al. Symptomatic Epstein-Barr virus infection and multiple sclerosis. , 1993, Journal of neurology, neurosurgery, and psychiatry.
[84] M. Karlsson,et al. Borrelia burgdorferi‐specific intrathecal antibody production in neuroborreliosis , 1993, Neurology.
[85] C. Bonnier,et al. Neuroborreliosis Revealed By Epilepsy , 1993 .
[86] L. Zöller,et al. Western blot as a tool in the diagnosis of Lyme borreliosis , 1993, Electrophoresis.
[87] G. Baranton,et al. Polymerase chain reaction with the 30-kb circular plasmid of Borrelia burgdorferi B31 as a target for detection of the Lyme borreliosis agents in cerebrospinal fluid. , 1993, Research in microbiology.
[88] P. Coyle. Neurologic complications of Lyme disease. , 1993, Rheumatic diseases clinics of North America.
[89] E. Fikrig,et al. Serologic response to the Borrelia burgdorferi flagellin demonstrates an epitope common to a neuroblastoma cell line. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[90] M. Weller,et al. CSF and serum ganglioside antibody patterns in MS , 1992, Acta neurologica Scandinavica.
[91] R. Bergamaschi,et al. Neuropsychological assessment in MS: clinical, neurophysiological and neuroradiological relationships , 1992, Acta neurologica Scandinavica.
[92] A. Lebech,et al. Roxithromycin in Lyme borreliosis: discrepant results of an in vitro and in vivo animal susceptibility study and a clinical trial in patients with erythema migrans. , 1992, Acta dermato-venereologica.
[93] A. Lebech,et al. Detection of Borrelia burgdorferi DNA in urine samples and cerebrospinal fluid samples from patients with early and late Lyme neuroborreliosis by polymerase chain reaction , 1992, Journal of clinical microbiology.
[94] Beck Rw. Corticosteroid treatment of optic neuritis: A need to change treatment practices , 1992 .
[95] T. Olsson,et al. Virus-reactive and autoreactive T cells are accumulated in cerebrospinal fluid in multiple sclerosis , 1992, Journal of Neuroimmunology.
[96] M. LeDoux,et al. Lyme neuroborreliosis manifesting as an intracranial mass lesion. , 1992, Neurosurgery.
[97] Rice Gp. Virus-induced demyelination in man: models for multiple sclerosis. , 1992 .
[98] Neil R. Miller,et al. A Randomized, Controlled Trial of Corticosteroids in the Treatment of Acute Optic Neuritis , 1992 .
[99] J. Halperin,et al. PCR detection of Borrelia burgdorferi DNA in cerebrospinal fluid of Lyme neuroborreliosis patients , 1992, Neurology.
[100] D. Isenberg,et al. Autoimmunity associated with infection: leprosy, acute rheumatic fever and lyme disease , 1991, Current Biology.
[101] R. McGhee,et al. Magnetic resonance imaging correlates of neuropsychological impairment in multiple sclerosis. , 1992, The Journal of neuropsychiatry and clinical neurosciences.
[102] 南後 健一. Ontogeny of thymic B cells in normal mice , 1992 .
[103] R. Beck. Corticosteroid treatment of optic neuritis: a need to change treatment practices. The Optic Neuritis Study Group. , 1992, Neurology.
[104] R. Lange,et al. Sequence homology between spirochaete flagellin and human myelin basic protein. , 1992, Immunology today.
[105] G. Peltz,et al. Borrelia burgdorferi activates a T helper type 1-like T cell subset in Lyme arthritis , 1991, The Journal of experimental medicine.
[106] Jean Côté,et al. Lyme Disease , 1991, International journal of dermatology.
[107] S. Ikehara,et al. Distinct mechanisms of neonatal tolerance induced by dendritic cells and thymic B cells , 1991, The Journal of experimental medicine.
[108] T. A. S. Group. The Canadian cooperative trial of cyclophosphamide and plasma exchange in progressive multiple sclerosis , 1991, The Lancet.
[109] A. Lebech,et al. LYME NEUROBORRELIOSIS: A NEW SENSITIVE DIAGNOSTIC ASSAY FOR INTRATHECAL SYNTHESIS OF BORRELIA BURGDORFERI—SPECIFIC IMMUNOGLOBULIN G, A, AND M , 1992 .
[110] L. Sigal. Molecular mimicry and Lyme borreliosis , 1990, Annals of neurology.
[111] H. Rasmussen,et al. Antibody reactivity against animal retroviruses in multiple sclerosis , 1990, Acta neurologica Scandinavica.
[112] M. Brainin,et al. [Recurrent and relapsing course of borreliosis of the nervous system]. , 1990, Wiener klinische Wochenschrift.
[113] A. Pachner. Neurological manifestations of Lyme disease. , 1990, New Jersey medicine : the journal of the Medical Society of New Jersey.
[114] H. Pfister,et al. Cefotaxime vs penicillin G for acute neurologic manifestations in Lyme borreliosis. A prospective randomized study. , 1989, Archives of neurology.
[115] P. Gorelick. Clues to the mystery of multiple sclerosis. , 1989, Postgraduate medicine.
[116] R. Martin,et al. Autoimmunity in Lyme disease: molecular cloning of antigens recognized by antibodies in the cerebrospinal fluid. , 1989, Autoimmunity.
[117] A. Pachner. Borrelia burgdorferi in the Nervous System: The New “Great Imitator” , 1988, Annals of the New York Academy of Sciences.
[118] M. Nuwer,et al. Clinical experience with azathioprine: The pros , 1988, Neurology.
[119] P. Rudge. Cyclosporine and multiple sclerosis: The cons , 1988, Neurology.
[120] D. Dommasch. Comparative clinical trial of cyclosporine in multiple sclerosis: The pros , 1988, Neurology.
[121] P. Francioli,et al. Guillain-Barré syndrome following Campylobacter jejuni enteritis. Report of three cases and review of the literature. , 1988, Archives of internal medicine.
[122] L. Kotilinek,et al. Search for autonomously proliferating spinal fluid lymphocytes in patients with multiple sclerosis , 1988, Neurology.
[123] W Fierz,et al. Cyclosporine versus azathioprine in the long‐term treatment of multiple sclerosis—results of the german multicenter study , 1988, Annals of neurology.
[124] D. Spencer,et al. Corpus callosotomy for epilepsy. , 1988, Neurology.
[125] K Rammohan,et al. Magnetic resonance imaging correlates of dementia in multiple sclerosis. , 1987, Archives of neurology.
[126] V. Dubowitz,et al. DERMATOMYOSITIS, POLYMYOSITIS, AND COXSACKIE-B-VIRUS INFECTION , 1987, The Lancet.
[127] N. Bowles,et al. Coxsackie B myocarditis. , 1987, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[128] V. Dubowitz,et al. The role of Coxsackie B viruses in the pathogenesis of myocarditis, dilated cardiomyopathy and inflammatory muscle disease. , 1987, Biochemical Society symposium.
[129] A. Steere,et al. Proliferative responses of mononuclear cells in Lyme disease. Reactivity to Borrelia burgdorferi antigens is greater in joint fluid than in blood. , 1986, Arthritis and rheumatism.
[130] H. Pfister,et al. Intrathecal production of specific antibodies against Borrelia burgdorferi in patients with lymphocytic meningoradiculitis (Bannwarth's syndrome). , 1986, The Journal of infectious diseases.
[131] R. Sayetta. Theories of the etiology of multiple sclerosis: a critical review. , 1986, Journal of clinical & laboratory immunology.
[132] D. McFarlin,et al. Viral antibodies in twins with multiple sclerosis , 1985, Neurology.
[133] R. Roos. Viruses and DemyeSinating Disease of the Centra! Nervous System , 1983, Neurologic Clinics.
[134] JOHN R. Martin,et al. HERPES SIMPLEX VIRUS TYPES 1 AND 2 AND MULTIPLE SCLEROSIS , 1981, The Lancet.
[135] S. Cook,et al. Multiple sclerosis and viruses , 1980, Neurology.
[136] G. Johnson,et al. ATROPHIC GASTRITIS AND DERMATITIS HERPETIFORMIS , 1974 .
[137] F. Oechsli. Letter: Oral contraception and sex ratio at birth. , 1974, Lancet.